申请人:Klumpp Klaus
公开号:US20070042988A1
公开(公告)日:2007-02-22
The invention provides novel nucleoside compounds of formula I wherein R
1
, R
2a
, R
2b
, R
3
, R
4
, R
5
, R
6
, R
8a
, R
9
and R
10
are as defined herein which are useful for the treatment of Hepatitis C Virus (HCV) mediated diseases. The invention further provides methods for treatment or prophylaxis of HCV mediated diseases with compounds of formula I and pharmaceutical compositions comprising these compounds,
该发明提供了一种新颖的核苷类化合物,其化学式为I,其中R1、R2a、R2b、R3、R4、R5、R6、R8a、R9和R10如本文所定义,这些化合物对治疗由丙型肝炎病毒(HCV)介导的疾病是有用的。该发明还提供了使用化合物I的方法进行治疗或预防HCV介导的疾病,以及包含这些化合物的药物组合物。